Skip to content

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery An international, multi-centre, randomized controlled trial to assess transfusion thresholds in younger patients undergoing cardiac surgery.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048759
Enrollment
1440
Registered
2023-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: 1) Restrictive transfusion strategy 2) Liberal transfusion strategy: Study participants will be randomized to one of the following transfusion strategies in a 1:1 manner: ï?· Restricti
4.7 mmol/L) intraoperatively and/or postoperatively. ï?· Liberal transfusion strategy: patients will receive a RBC transfusion if their Hb concentration is 95 g/L (9.5 g/dL
5.9 mmol/L) intraoperatively, or postoperatively in the ICU
or 85 g/L (8.5 g/dL
5.3 mmol/L) on the ward.

Sponsors

Dr David Mazer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. >=18 and 2. Planned cardiac surgery using cardiopulmonary bypass 3. Informed consent obtained 4. Preoperative European System for Cardiac Operative Risk Evaluation (EuroSCORE I) of 6 or more.

Exclusion criteria

Exclusion criteria: 1. Patients who refuse participation 2. Patients who are unable to receive or who refuse blood products 3. Patients who are involved in a preoperative autologous pre-donation program 4. Patients who are having a heart transplant or having surgery solely for an insertion of a ventricular assist device 5. Pregnancy or lactation (a negative pregnancy test must be obtained prior to randomization for women of childbearing potential)

Design outcomes

Primary

MeasureTime frame
The primary outcome is primary composite endpoint of all-cause mortality, myocardial infarction defined in accordance with the 4th Universal Definition of Myocardial Infarction, new-onset renal failure with dialysis, or new focal neurological deficit (stroke) lasting more than 24 hours confirmed by clinical and/or computed tomographic scan, occurring within 6 months of the initial surgeryTimepoint: 6 months

Secondary

MeasureTime frame
) Incidence of each individual component of the primary outcome: all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke) within 6 months 2) Composite and individual all-cause mortality, myocardial infarction, new onset renal failure requiring dialysis, and new focal neurological deficit (stroke) with index hospitalization or after 28 days postoperatively, whichever comes first 3) Length of stay in the Intensive Care Unit (ICU) and hospital (index hospitalization) 4) Prolonged low output state defined as the need for two or more inotropes for 24 hours or more, intra-aortic balloon pump or ventricular assist device postoperatively (index hospitalization) 5) Duration of mechanical ventilation (index hospitalization)Timepoint: 6 Months

Countries

Canada, India, Russian Federation

Contacts

Public ContactDrChirag Mehta

Epic Hospital

chiragdr69@gmail.com9825016956

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026